Epitranscriptomics Crosstalks and Toxicants (EPCOT) (R01 Clinical Trials Not Allowed)
ID: 357119Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Award Range

$0 - $500K

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/357119

Additional Information

http://grants.nih.gov/grants/guide/rfa-files/RFA-ES-25-001.html
Timeline
    Description

    The National Institutes of Health (NIH) is inviting proposals for the "Epitranscriptomics Crosstalks and Toxicants (EPCOT)" funding opportunity, aimed at exploring the impact of environmental toxicants on epitranscriptomic crosstalks and their implications for health outcomes. This initiative seeks innovative R01 applications that will provide mechanistic insights into how these interactions may contribute to the initiation, progression, or exacerbation of adverse health effects. The NIH plans to allocate approximately $4 million to fund 5-6 projects over a maximum duration of five years, with each application budget capped at $500,000 in direct costs. Interested applicants must submit their proposals by February 7, 2025, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    RFA-ES-25-001-Full-Announcement.html
    RFA-ES-25-001.html
    The National Institutes of Health (NIH) is inviting proposals for the "Epitranscriptomics Crosstalks and Toxicants (EPCOT)" funding opportunity, under the R01 Research Project Grant mechanism. The initiative aims to investigate how environmental toxicants affect epitranscriptomic crosstalks, which are interactions between epitranscriptomic and epigenomic marks that may influence health outcomes. The goal is to enhance understanding of the mechanisms through which these exposures contribute to diseases. NIH intends to allocate $4 million to fund 5-6 projects over a maximum duration of five years, with an application budget capped at $500,000 in direct costs. Eligible applicants include various educational and public institutions, nonprofits, and small businesses, while applications must comply with specific guidelines and utilize updated NIH forms. The application process requires early registration with relevant platforms, and submissions are due by February 7, 2025. The review process, focusing on the project's significance, rigor, and investigator expertise, will ultimately assess the impact and feasibility of the proposed research in addressing critical public health challenges related to environmental exposures.
    Similar Opportunities
    Research to Action: Assessing and Addressing Community Exposures to Environmental Contaminants (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a grant opportunity titled "Research to Action: Assessing and Addressing Community Exposures to Environmental Contaminants," aimed at fostering community-engaged research to identify and mitigate health risks associated with environmental exposures. This initiative encourages multidisciplinary projects that actively involve community members in defining research questions and methodologies, with the goal of developing actionable public health plans based on research findings. The program is particularly focused on addressing health disparities and promoting environmental health justice, with a maximum funding amount of $500,000 available for direct costs over a period of up to five years. Interested applicants can find more information and apply by visiting the provided link or contacting the NIH OER Webmaster at OERWebmaster03@od.nih.gov, with applications due by September 7, 2025.
    Time-Sensitive Research Opportunities in Environmental Health Sciences (R21 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Time-Sensitive Research Opportunities in Environmental Health Sciences" (NOFO RFA-ES-23-011) aimed at supporting urgent research in environmental health. This initiative focuses on addressing pressing environmental health issues arising from unpredictable events, such as natural disasters and policy changes, facilitating rapid data collection and analysis of human biological samples. With a total budget of $800,000 annually and individual awards capped at $275,000 over a maximum of two years, the program emphasizes an expedited review process, allowing for a complete cycle from submission to award within 4-6 months. Interested applicants can find more information and submit inquiries via email at grantsinfo@nih.gov, with applications due by December 1, 2025.
    Time-Sensitive Research Opportunities in Environmental Health Sciences (R21 Clinical Trials Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Time-Sensitive Research Opportunities in Environmental Health Sciences (R21 Clinical Trials Not Allowed)," aimed at supporting innovative research during critical events that require rapid data collection on human health impacts. This initiative seeks to understand the consequences of natural and human-made disasters and significant policy changes, emphasizing the need for expedited research processes that allow for funding decisions within 4-6 months of application submission. Eligible applicants include a diverse range of organizations, such as higher education institutions, nonprofits, and tribal governments, with a total funding amount of $800,000 available to support 4-5 grants. Interested parties can find more information and apply by visiting the NIH grants website, with the application deadline set for December 1, 2025.
    High-Priority Research in Tobacco Regulatory Science (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for "High-Priority Research in Tobacco Regulatory Science" aimed at advancing scientific understanding of tobacco products to inform regulations by the Food and Drug Administration (FDA). This initiative invites R01 applications focused on critical research areas, including addiction, health impacts, and the toxicity of electronic nicotine delivery systems (ENDS) and other tobacco products. The funding is crucial for generating data that will guide FDA's regulatory decisions, ultimately protecting public health. Each application can request up to $500,000 per year for a project period of up to five years, with a total of $4 million available across five awards. Applications are due by June 7, 2025, and interested parties can contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Translational Exploratory/Developmental Research Projects (R21 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity under the CCRP Initiative for Countermeasures Against Chemical Threats (CounterACT), aimed at supporting translational exploratory/developmental research projects that advance novel medical countermeasures (MCMs) for serious health impacts resulting from acute exposure to toxic chemical threats. The initiative specifically seeks projects that develop or repurpose existing FDA-approved products as potential treatments, generating preliminary data necessary for broader NIH support, while excluding basic research or environmental decontamination technologies. This funding opportunity has a ceiling of $275,000 over a two-year period, with applications due by May 30, 2025. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov for inquiries.
    Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the Chemical Countermeasures Research Program (CCRP) Initiative, aimed at supporting research on the harmful effects of acute exposure to Ultra-Potent Synthetic (UPS) opioids, such as fentanyl and carfentanil. This initiative seeks to advance understanding of both immediate and delayed health impacts associated with these substances, emphasizing innovative research into toxicity mechanisms and the development of new therapeutic strategies. The program will provide up to four grants, with a maximum award of $300,000 annually over a potential five-year period, totaling an estimated $2 million in funding. Interested applicants, including various educational and nonprofit institutions, must submit their proposals by November 18, 2027, and can direct inquiries to grantsinfo@nih.gov for further information.
    Environmental Health Sciences Core Centers Program (P30 Clinical Trials Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the Environmental Health Sciences Core Centers Program (EHSCC), aimed at establishing research hubs that focus on environmental health science. This program seeks to enhance understanding of the impact of environmental exposures on human health, with an emphasis on interdisciplinary collaboration among investigators and community engagement, as outlined in the NIEHS Strategic Plan for 2025-2029. Eligible applicants include a variety of organizations such as higher education institutions and nonprofits, with a requirement for demonstrated peer-reviewed research funding of at least $3 million annually. The NIH plans to commit $6 million to fund up to four awards, with the earliest application submission date set for February 18, 2025, and a final close date of January 29, 2027. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
    CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Basic Research on Chemical Threats that Affect the Nervous System (R01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "NIH Countermeasures Against Chemical Threats (CounterACT) Basic Research on Chemical Threats that Affect the Nervous System." This initiative invites applications for basic research projects focused on understanding the mechanisms of toxicity of chemical warfare agents and toxic industrial chemicals that impact the nervous system, with the aim of developing potential therapeutic countermeasures for civilian exposure. The program is particularly significant in enhancing public health responses to chemical threats, emphasizing innovative and transdisciplinary research approaches. Up to four grants totaling $2 million are anticipated for fiscal year 2026, with applications due by 5 PM local time on October 17, 2026. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov for inquiries.
    CCRP Initiative: Chemical Threat Agent-induced Pulmonary and Ocular Pathophysiological Mechanisms (R01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a Notice of Funding Opportunity (NOFO) titled "CCRP Initiative: Chemical Threat Agent-induced Pulmonary and Ocular Pathophysiological Mechanisms," aimed at supporting research into the mechanisms of chemical toxicity affecting the lungs and eyes. This initiative seeks to fund projects that explore the health impacts of chemical threat agents, with a focus on identifying molecular and genetic targets for therapeutic countermeasures, utilizing various research methodologies such as animal models and computational modeling. A total of approximately $3 million is available to support up to five grants, with each project eligible for a maximum budget of $300,000 per year over a three-year period. Interested applicants should note that the application period opens on August 24, 2024, with a final submission deadline of September 24, 2026, and can direct inquiries to grantsinfo@nih.gov for further information.
    Tobacco Regulatory Science (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the "Tobacco Regulatory Science (R01 Clinical Trial Optional)" funding opportunity, aimed at supporting biomedical and behavioral research to inform the regulation of tobacco products and protect public health. This initiative seeks R01 research project grant applications that address key research priorities, including the composition and design of tobacco products, toxicity assessments, addiction studies, and the health effects of tobacco use. A total of up to six R01 grants, with a combined funding of $4 million for fiscal year 2024, will be awarded to eligible applicants, which include a diverse range of institutions and organizations. Interested parties should submit their applications by May 4, 2025, and can direct inquiries to NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-23-017.html for further details.